DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

14.55 0.24 (1.68%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CLDX $14.55 1.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.30
Previous Close $14.31
Daily Range $13.81 - $14.74
52-Week Range $10.76 - $38.84
Market Cap $1.3B
P/E Ratio -11.93
Dividend (Yield) $0.00 (0.0%)
Volume 1,977,857
Average Daily Volume 1,955,843
Current FY EPS -$1.32

Sector

Healthcare

Industry

Drugs

Celldex Therapeutics, Inc. (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website: http://www.celldex.com/

News & Commentary Rss Feed

Down 47%: Why the Market is Wrong About Celldex Stock

Celldex Therapeutics's epic decline begun once the company shut down CDX-1135, but are the losses warranted, or is the company now presenting great value?

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

5 Companies Developing New Cancer Drugs

Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies

Celldex Therapeutics' (CLDX) CEO Anthony Marucci on Q2 2014 Results - Earnings Call Transcript

Celldex Therapeutics (CLDX) Q2 2014 Results - Earnings Call Webcast

Celldex Therapeutics (CLDX) Is Today's Perilous Reversal Stock

Celldex Therapeutics (CLDX) Is Today's Dead Cat Bounce Stock

Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatm

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment

See More CLDX News...

CLDX's Top Competitors

CLDX $14.55 (1.68%)
Current stock: CLDX
AMGN $132.82 (0.22%)
Current stock: AMGN
GILD $103.96 (1.65%)
Current stock: GILD
BIIB $339.97 (0.39%)
Current stock: BIIB